Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women

BACKGROUND: The objective of this study was to determine whether the 3-dose quadrivalent human papillomavirus (HPV) vaccine series (HPV-6, -11, -16, -18) is immunogenic and safe in young women infected with human immunodeficiency virus (HIV). METHODS: We enrolled 99 women aged 16–23 years in a phase...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kahn, Jessica A., Xu, Jiahong, Kapogiannis, Bill G., Rudy, Bret, Gonin, René, Liu, Nancy, Wilson, Craig M., Worrell, Carol, Squires, Kathleen E.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2013
Teme:
HIV/AIDS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3739463/
https://ncbi.nlm.nih.gov/pubmed/23667266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cit319
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki